|
| ID |
DDInter229 |
| Drug Type |
small molecule |
| Molecular Formula |
C11H17Brn |
| Molecular Weight |
243.168
|
| Description |
Bretylium is a norepinephrine release inhibitor used for the prophylaxis and therapy of ventricular fibrillation, as well as the treatment of life-threatening ventricular arrhythmias.
|
| ATC Classification |
C01BD02
|
| IUPAC Name |
[(2-Bromophenyl)Methyl](Ethyl)Dimethylazanium |
| InChI |
Inchi=1S/C11H17Brn/C1-4-13(2,3)9-10-7-5-6-8-11(10)12/H5-8H,4,9H2,1-3H3/Q+1 |
| InChI Key |
AAQOQKQBGPPFNS-UHFFFAOYSA-N |
| Canonical SMILES |
CC[N+](C)(C)CC1=CC=CC=C1Br |
| Useful Links |
DrugBank
ChEMBL
PubChem
|